Home>Topics>Finance>Technology>Biotechnology

Biotechnology

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. 3 Biotech Catalyst Stocks To Own

    Headlines

    Thu, 31 Jul 2014

    By Alexander Maxwell : For companies involved in the research of drugs, no catalyst is able to trump coming out with clinical trial results. For each of the companies mentioned in this article, investors are expecting results rather soon--and with large implications. These results have the ...

  2. Cramer's Lightning Round - 6 Biotech Picks (7/30/14)

    Headlines

    Thu, 31 Jul 2014

    NASDAQ: BIIB ), Gilead (NASDAQ: GILD ), Seattle Genetics (NASDAQ: SGEN ), Isis Pharmaceuticals (NASDAQ: ISIS ): "In biotech , I like Regeneron, Celgene, Biogen Idec and Gilead. I also like Seattle Genetics and Isis Pharmaceuticals." EMC (NYSE

  3. BRIEF-Sangui Biotech says Granulox technology patent now legally binding

    Headlines

    Thu, 31 Jul 2014

    July 31 (Reuters) - Sangui Biotech International Inc : * Says Granulox technology patent now legally binding * Patent protection now applies to all member countries of European union and

  4. It Is Possible to Outperform the Broad Market Indices Over the Long Term

    Headlines

    Wed, 30 Jul 2014

    returns than the 7.3% ann. return for the average S&P 500 index fund and even the 8.3% ann. return for VTSMX. Health & Biotech 11.7% Utilities 10.7 Emerging Markets 11.2 Natural Resources 11.7 While the indices during this period did moderately

  5. New Morningstar Analyst Report for Icon PLC

    Stock Reports

    Wed, 30 Jul 2014

    development and clinical testing services to pharmaceutical, biotechnology , and medical device companies. While the vast majority of ..... rates and the outsourcing decisions of pharmaceutical and biotech firms. We believe pharmaceutical firms will continue to outsource

  6. New Morningstar Analyst Report for Covance Inc

    Stock Reports

    Wed, 30 Jul 2014

    to win a strategic partnership from Big Pharmaceutical and biotech firms. We award Covance a Standard stewardship rating. CEO ..... spending rates and the outsourcing decisions of pharmaceutical and biotech firms. We believe pharmaceutical firms will continue to outsource

  7. Why You Should Consider Investing In Man's Best Friend

    Headlines

    Wed, 30 Jul 2014

    By Diamond Technology Management : Situation: Kindred Biosciences(NASDAQ: KIN ) is a biotechnology company that develops medicine for pets. Kindred seeks to identify drugs that have been validated in humans and develop animal

  8. Stock futures add to gains after better than expected GDP data

    Headlines

    Wed, 30 Jul 2014

    Twitter's Q2 results crushed Wall Street forecasts; TWTR +23% in heavy premarket volume. Amgen is expected to underpin the biotech space after reporting better than expected results. The economic news has sparked some selling in the Treasury market, where

  9. Gilead's Massive Undervaluation: A Pictorial Overview

    Headlines

    Wed, 30 Jul 2014

    shares to my portfolio as I believe the Sovaldi juggernaut is just getting unleashed. I was especially active during the big biotech sell-off that triggered a decline into the mid $60's in March. This was a gift I do not believe will be repeated any

  10. New Morningstar Analyst Report for Regeneron Pharmaceuticals Inc

    Stock Reports

    Wed, 30 Jul 2014

    is the former CEO of Merck, and includes several seasoned biotech and pharma executives and scientific luminaries, notably three ..... acquisition (Regeneron regularly ranks high on Morningstar's biotech takeout list each year), especially as the antibody programs

« Prev12345Next »
Content Partners